Cargando…
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
Amyotrophic lateral sclerosis is a progressive and fatal disease that causes motoneurons degeneration and functional impairment of voluntary muscles, with limited and poorly efficient therapies. Alterations in the Nrf2-ARE pathway are associated with ALS pathology and result in aberrant oxidative st...
Autores principales: | Arslanbaeva, Liaisan, Bisaglia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911691/ https://www.ncbi.nlm.nih.gov/pubmed/35268572 http://dx.doi.org/10.3390/molecules27051471 |
Ejemplares similares
-
Adaptive redox homeostasis in cutaneous melanoma
por: Arslanbaeva, Liaisan R., et al.
Publicado: (2020) -
UBIAD1 and CoQ10 protect melanoma cells from lipid peroxidation-mediated cell death
por: Arslanbaeva, Liaisan, et al.
Publicado: (2022) -
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
por: Bono, Silvia, et al.
Publicado: (2021) -
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018) -
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS
por: Petri, Susanne, et al.
Publicado: (2012)